Analysis of the structure of mycolic acids of Mycobacterium simiae reveals a particular composition of α-mycolates in strain ‘habana’ TMC 5135, considered as immunogenic in tuberculosis and leprosy

References

1. Astola J., Muñoz M., Sempere M., Coll P., Luquin M., Valero-Guillén P. L. 2002; The HPLC-double-cluster pattern of some Mycobacterium gordonae strains is due to their dicarboxy-mycolate content. Microbiology 148:3119–3127
   [Google Scholar]
2. Baess I., Magnusson M. 1982; Classification of Mycobacterium simiae by means of comparative reciprocal intradermal sensitin testing on guinea pigs and deoxyribonucleic acid hybridization. Acta Pathol Microbiol Immunol Scand [ B ] 90:101–107
   [Google Scholar]
3. Barry C. E. III, Lee R. E., Mdluli K., Sampson A. E., Schroeder B. G., Slayden R. A., Yuan Y. 1998; Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res 37:143–179
   [Google Scholar]
4. Beckman E. M., Porcelli S. A., Morita C. T., Behar S. M., Furlong S. T., Brenner M. B. 1994; Recognition of a lipid antigen by CD1-restricted αβ ⁺ T cells. Nature 372:691–694
   [Google Scholar]
5. Bhatt A., Fujiwara N., Bhatt K., Gurcha S. S., Kremer L., Cheng B., Chan J., Porcelli S. A., Kobayashi K. other authors 2007; Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A 104:5157–5162
   [Google Scholar]
6. Brennan P. J., Nikaido H. 1995; The envelope of mycobacteria. Annu Rev Biochem 64:29–63
   [Google Scholar]
7. Butler W. R., Guthertz L. S. 2001; Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev 14:704–726
   [Google Scholar]
8. Daffé M., Draper P. 1998; The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131–203
   [Google Scholar]
9. de la Salle H., Mariotti S., Angenieux C., Gilleron M., García-Alles L.-F., Malm D., Berg T., Paoletti S., Maître B. other authors 2005; Assistance of microbial glycolipid antigen processing by CD1e. Science 310:1321–1324
   [Google Scholar]
10. Dubnau E., Chan J., Raynaud C., Mohan V. P., Lanéelle M. A., Yu K., Quémard A., Smith I., Daffé M. 2000; Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36:630–637
    [Google Scholar]
11. Falkinham J. O. III 1996; Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177–215
    [Google Scholar]
12. Geisel R. E., Sakamoto K., Russel D. G., Rhoades E. R. 2005; In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette–Guérin is due principally to trehalose mycolates. J Immunol 174:5007–5015
    [Google Scholar]
13. Khoo K. H., Chaterjee D., Dell A., Morris H. R., Brennan P. J., Draper P. 1996; Novel O -methylated terminal glucuronic acid characterizes the polar glycopeptidolipids of Mycobacterium habana TMC 5135. J Biol Chem 271:12333–12342
    [Google Scholar]
14. Mederos L. M., Gutiérrez A. M., Valdivia J. A. 1992; Utilization of a new culture medium in biochemical tests for the mycobacterial classification. Mem Inst Oswaldo Cruz 87:441
    [Google Scholar]
15. Mederos L. M., Valdivia J. A., Valero-Guillén P. L. 1998; Analysis of lipids reveals differences between ‘ Mycobacterium habana ’ and Mycobacterium simiae . Microbiology 144:1181–1188
    [Google Scholar]
16. Mederos L. M., Valdivia J. A., Valero-Guillén P. L. 2006; Lipids of ‘ Mycobacterium habana ’, a synonym of Mycobacterium simiae with vaccine potential. Tuberculosis ( Edinb ) 86:324–329
    [Google Scholar]
17. Meissner G., Schröder K. H. 1975; Relationships between Mycobacterium simiae and Mycobacterium habana . Am Rev Respir Dis 111:196–200
    [Google Scholar]
18. Minnikin D. E. 1982; Lipids: complex lipids. In The Biology of the Mycobacteria vol. 1 pp 95–184 Edited by Ratledge C., Stanford J. L. London: Academic Press;
    [Google Scholar]
19. Minnikin D. E., Hutchinson I. G., Caldicott A. B., Goodfellow M. 1980; Thin-layer chromatography of methanolysates of mycolic-acid containing bacteria. J Chromatogr 188:221–233
    [Google Scholar]
20. Minnikin D. E., Minnikin S. M., Parlett J. H., Goodfellow M., Magnusson M. 1984; Mycolic acid patterns of some species of Mycobacterium . Arch Microbiol 139:225–231
    [Google Scholar]
21. Rao V., Fujiwara N., Porcelli S. A., Glickman M. S. 2005; Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201:535–543
    [Google Scholar]
22. Rao V., Gao F., Chen B., Jacobs W. R. Jr, Glickman M. S. 2006; Trans -cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest 116:1660–1667
    [Google Scholar]
23. Rhoades E., Hsu F. F., Torrelles J. B., Turk J., Chaterjee D., Russell D. G. 2003; Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol 48:875–888
    [Google Scholar]
24. Riley L. W. 2006; Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope and pathogenesis. J Clin Invest 116:1475–1478
    [Google Scholar]
25. Schaible U. E., Kaufmann S. H. E. 2000; CD1 and CD1-restricted T cells in infections with intracellular bacteria. Trends Microbiol 8:419–425
    [Google Scholar]
26. Takayama K., Wang C., Besra G. S. 2005; Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis . Clin Microbiol Rev 18:81–101
    [Google Scholar]
27. Valdés I., Montoro E., Valdidia J. A., Aguilar D., Orozco E., Hernández-Pando R. 2007a; Immunogenicity induced by three strains of Mycobacterium habana in BALB/c model of progressive pulmonary tuberculosis. In TB07 Vaccines. International Workshop on Tuberculosis Vaccines. Program and Abstract Book P37
    [Google Scholar]
28. Valdés I., Montoro E., Valdidia J. A., Orozco E., Aguilar D., Hernández-Pando R. 2007b; Virulence of Mycobacterium habana strains in a BALB/c model of progressive pulmonary tuberculosis. In TB07 Vaccines. International Workshop on Tuberculosis Vaccines. Program and Abstract Book P38
    [Google Scholar]
29. Valdivia J. A. 1973; Mycobacterium habana : clinical and epidemiological significance. Ann Soc Belg Med Trop 53:263–266
    [Google Scholar]
30. Watanabe M., Ohta A., Sasaki A., Minnikin D. E. 1999; Structure of a new glycolipid from the Mycobacterium avium – Mycobacterium intracellulare complex. J Bacteriol 181:2293–2297
    [Google Scholar]
31. Watanabe M., Aoyagi Y., Ridell M., Minnikin D. E. 2001; Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147:1825–1837
    [Google Scholar]
32. Watanabe M., Aoyagi Y., Mitome H., Fujita T., Naoki H., Ridell M., Minnikin D. E. 2002; Location of functional groups in mycobacterial meroaldhyde chains; the recognition of new structural principles in mycolic acids. Microbiology 148:1881–1902
    [Google Scholar]
33. Weiszfeiler J. G., Karczag E. 1976; Synonymy of Mycobacterium simiae Karasseva et al . 1965 and Mycobacterium habana Valdivia et al . 1971. Int J Syst Bacteriol 26:474–477
    [Google Scholar]